Consensus Omeros Corporation

Equities

OMER

US6821431029

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
3.04 USD -1.62% Intraday chart for Omeros Corporation -8.98% -7.03%

Evolution of the average Target Price on Omeros Corporation

Price target over the last 5 years

History of analyst recommendation changes

625968d7bc41693eb66fa30e.1xrlwPLJW-Kbysm153KhWv1zvrcOvrzhYz8BmmrtrRs.iEyi-Z-FMrvKrLjlrQTVEJA08-dc-Pm4FXFl-1iV7FqWW7KDuLkcmPyGpg~88e7de0d7f7c70dd34a29e6df7270507
UBS Adjusts Omeros Price Target to $4 From $2, Maintains Neutral Rating MT
UBS Downgrades Omeros to Neutral From Buy, Adjusts Price Target to $2 From $12 MT
BofA Securities Downgrades Omeros to Underperform Rating From Neutral, Price Target is $3 MT
BofA Securities Downgrades Omeros to Neutral From Buy, Sets $4 Price Target MT
Cantor Fitzgerald Adjusts Omeros' Price Target to $20 From $34, Reiterates Overweight Rating MT
OMEROS : HC Wainwright Adjusts Price Target on Omeros to $12 From $19, Maintains Buy Rating MT
OMEROS : UBS Adjusts Price Target on Omeros to $13 From $25 on Drug Filing Deficiencies, Maintains Buy Rating MT
OMEROS : Wedbush Suspended Coverage on Omeros MT
OMEROS : JPMorgan Downgrades Omeros to Underweight from Neutral MT
OMEROS : HC Wainwright Adjusts Omeros' Price Target to $19 from $32, Keeps Buy Rating MT
OMEROS : Maxim Downgrades Omeros to Hold from Buy MT
OMEROS : Wedbush Downgrades Omeros to Underperform From Neutral, Lowers PT to $5 From $18 After FDA Delays PDUFA For Narsoplimab MT
OMEROS : Maxim Group Downgrades Omeros to Hold From Buy MT
Omeros : Shares Sink After Receiving JPMorgan's Neutral Rating MT
OMEROS : JPMorgan Starts Omeros at Neutral With $15 Price Target MT
OMEROS : WBB Securities Reinstates Omeros With Strong Buy, $100 Price Target MT
OMEROS : HC Wainwright Adjusts Omeros' Price Target to $32 From $34, Keeps Buy Rating MT
OMEROS : UBS Starts Omeros at Buy With $25 Price Target MT
OMEROS : HC Wainwright Adjusts Omeros' Price Target to $34 from $31, Keeps Buy Rating MT
OMEROS : Wedbush Adjusts Omeros' Price Target to $18 From $13, Maintains Neutral Rating MT
OMEROS : Maxim Adjusts Omeros' Price Target to $25 from $20, Keeps Buy Rating MT
OMEROS : Wedbush Adjusts Omeros' Price Target to $13 From $12, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
3.04
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Omeros Corporation

UBS
BofA Securities
Cantor Fitzgerald
HC Wainwright
Wedbush
JPMorgan Chase
Maxim
WBB Securities
  1. Stock Market
  2. Equities
  3. OMER Stock
  4. Consensus Omeros Corporation